Repair of bone defects by applying biomatrices with and without autologous osteoblasts.

QUESTION Is it possible to stimulate osteoconduction and osteogenesis to improve bone formation in critical-size defects in order to avoid bone grafting? MATERIAL AND METHODS Full thickness, critical-sized defects were created in the anterior mandible of 16 adult mini-pigs. The defects were filled with a new bioactive matrix (60% hydroxyapatite and 40% beta-tricalciumphosphate), produced by an innovative low temperature sol-gel-process (120 degrees C). The biomatrix was tested alone and in combination with cultured autologous osteoblasts. In a control group, periosteum was the only bone producing source. Five weeks postoperatively, the animals were sacrificed and the defects analysed macroscopically, histologically and radiographically. RESULTS The highest rate of new bone formation was in the biomatrix group without osteoblasts (73% of the former defect). The biomatrix was degraded at the same speed as new bone was laid down. In the control group, bone formation of only 59% was observed. Additional transplantation of autologous osteoblasts in combination with the biomatrix did not result in more bone production than in the control group(!). CONCLUSION This new bioactive calciumphosphate matrix seems to be a promising bone replacement material.

[1]  K. Donath,et al.  A method for the study of undecalcified bones and teeth with attached soft tissues. The sawing and grinding technique , 1982 .

[2]  G. Holzhüter,et al.  Development of Bioactive Sol-Gel Material Template for In Vitro and In Vivo Synthesis of Bone Material , 2000 .

[3]  H. Tal,et al.  Histopathological morphometric evaluation of 2 different hydroxyapatite-bone derivatives in sinus augmentation procedures: a comparative study in humans. , 2001, Journal of periodontology.

[4]  K. Donath,et al.  A method for the study of undecalcified bones and teeth with attached soft tissues. The Säge-Schliff (sawing and grinding) technique. , 1982, Journal of oral pathology.

[5]  P. Proussaefs,et al.  Histologic evaluation of a hydroxyapatite onlay bone graft retrieved after 9 years: a clinical report. , 2002, The Journal of prosthetic dentistry.

[6]  T. Uemura,et al.  In vivo evaluation of a novel porous hydroxyapatite to sustain osteogenesis of transplanted bone marrow-derived osteoblastic cells. , 2001, Journal of biomedical materials research.

[7]  M. Kunkel,et al.  [Roentgen spectrometry comparison of currently available bone substitutes]. , 1999, Mund-, Kiefer- und Gesichtschirurgie : MKG.

[8]  Richard A. Kenley,et al.  Biotechnology and Bone Graft Substitutes , 1993, Pharmaceutical Research.

[9]  X. Wen,et al.  In vitro bioactive behavior of hydroxylapatite-coated porous Al(2)O(3). , 2000, Journal of biomedical materials research.

[10]  L. Landi,et al.  A 6-year unloaded hydroxyapatite-coated dental implant placed into an extraction socket in conjunction with nonresorbable hydroxyapatite grafting material: histologic evaluation. , 2002, The International journal of periodontics & restorative dentistry.

[11]  D. Shi,et al.  The effect of structural characteristics on the in vitro bioactivity of hydroxyapatite. , 2002, Journal of biomedical materials research.

[12]  I. Asahina,et al.  Evaluation of ceramics composed of different hydroxyapatite to tricalcium phosphate ratios as carriers for rhBMP-2. , 2001, Biomaterials.